Barra laterale dell'articolo

Scarica
Abbonamento o quota di accesso PDF (EUR 5)
Statistica
Leggi contatore : 629 Scarica : 18

Contenuto dell'articolo principale

Abstract

ABSTRACT

BACKGROUND. Prostate cancer is the most common cancer in men worldwide and nowadays several treatments are available, each presenting risks and benefits. Therefore, deciding on the most appropriate treatment is particularly challenging for men at the time of the diagnosis. AIM. This review was aimed at identifying, analyzing, and synthesizing the qualitative evidence on the experience of deciding about treatment after a diagnosis of localized Prostate cancer (LPC) METHODS. A meta-synthesis according to the meta-aggregation approach of the Joanna Briggs Institute (JBI) was used. The CINAHL, MEDLINE, and PsycINFO databases were searched for qualitative studies published from January 1998 to August 2018 in English and Italian. Qualita- tive Assessment and Review Instrument of JBI was used.

RESULTS. From the identified sixteen studies two synthesized findings were derived that describe the decision-making as a complex process made in condition of emotional distress and influenced by internal and external factors; men evaluate differently the possible risks and benefits of cancer treatment, and after deciding they try to cope with their choice.

CONCLUSION. The review provides evidence that men with LPC's need to receive emotional support and comprehensive information about the treatment options to facilitate their decision. The healthcare team should refer men to a multidisciplinary cancer service to permit access to all the treatment options.

KEY WORDS: Prostate cancer; experience; decision-making; qualitative research; review


L'esperienza di decidere sul miglior trattamento per un cancro prostatico localizzato: una meta-sintesi

RIASSUNTO

BACKGROUND. Il cancro della prostata è la neoplasia piuÌ€ comune negli uomini in tutto il mondo. Attualmente sono disponibili diversi trattamenti che presentano rischi e benefici. Ne consegue che scegliere il trattamento piuÌ€ opportuno è particolarmente difficile per gli uomini con una recente diagnosi di cancro prostatico.

OBIETTIVI. La presente revisione ha lo scopo di identificare, analizzare e sintetizzare l'evidenza qualitativa sull'esperienza di decidere riguardo al trattamento dopo una diagnosi di cancro prosta- tico localizzato (LCP).
METODI. E' stata condotta una meta-sintesi secondo l'approccio della meta-aggregazione racco- mandato dal Joanna Briggs Institute (JBI). Sono stati ricercati studi qualitativi pubblicati da gennaio 1998 ad agosto 2018 in lingua inglese e italiana sulle banche dati CINAHL, MEDLINE e PsycINFO. E' stata utilizzato lo strumento per le revisioni e la valutazione qualitativa del JBI. RISULTATI. Sono stati identificati 16 studi dai quali sono stati derivati due risultati sintetici che descrivono la presa di decisione come un processo complesso che avviene in condizioni di distress emozionale e che è influenzato da fattori interni ed esterni; gli uomini valutano differentemente i possibili rischi e benefici dei trattamenti del cancro e dopo aver preso la decisione, cercano di adat- tarsi alla decisione presa.

CONCLUSIONI. La revisione evidenzia come gli uomini con un tumore prostatico localizzato hanno bisogno di ricevere supporto emozionale e informazioni complete sulle opzioni di tratta- mento al fine di facilitare la loro decisione. Il team sanitario dovrebbe indirizzare gli uomini con una diagnosi recente di cancro prostatico a centri multidisciplinari che permettano loro l'accesso a tutte le opzioni di trattamento.

PAROLE CHIAVE: Cancro alla prostata, esperienza, processo decisionale, ricerca qualitativa, revisione

Dettagli dell'articolo

Come citare
Sferrazza, S., Accettone, R., Pampoorickel, K., Caggianelli, G., Casciato, S., Cinque, A., & Matarese, M. (2020). Men’s experiences of deciding about treatment for localized prostate cancer: a meta-synthesis. PROFESSIONI INFERMIERISTICHE, 72(4). Recuperato da https://www.profinf.net/pro3/index.php/IN/article/view/699
Scarica citazione
Endnote/Zotero/Mendeley (RIS)
BibTeX

Riferimenti

  • Bayliss, D., Duff, J., Stricker, P., & Walker, K. (2016). Decision- making in prostate cancer: active surveillance over other treatment options. Urologic Nursing, 36(3), 141-149.
  • Bayliss, R.D., Duff, J., Stricker, P. & Walker, K. (2017). Decision- making in prostate cancer. Choosing active surveillance over other treatment options: a literature review. Urologic Nursing, 37(1), 15-22.
  • Bergner, E. M., Cornish, E. K., Horne, K., Griffith, D. M. (2018). A qualitative meta-synthesis examining the role of women in African American men's prostate cancer screening and treatment decision making. Psychooncology, 27(3):781-790. doi: 10.1002/pon.4572
  • Berry, D. L, Ellis, W. J., Woods, N. F., Schwien, C., Mullen, K.H., & Yang, C. (2003). Treatment decision-making by men with localized prostate cancer: the influence of personal factors. Urologic Oncology, 21(2), 93-100. doi: 10.1016/S1078- 1439(02)00209-0
  • Bokhour, B. G., Clark, J. A., Inui, T. S., Silliman, R. A., & Talcott, J. A. (2001). Sexuality after treatment for early prostate cancer: exploring the meanings of "erectile dysfunction". Journal of General Internal Medicine, 16(10), 649-655. doi: 10.1111/j.1525-1497.2001.00832.x
  • Cohen, H., & Britten, N. (2003). Who decides about prostate cancer treatment? A qualitative study. Family Practice, 20(6), 724-729. doi: 10.1093/fampra/cmg617.
  • Davison, B. J., Oliffe, J. L., Pickles, T., & Mroz, L. (2009). Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer. Oncology Nursing Forum, 36(1), 89-96. doi: 10.1188/09.ONF.89-96
  • Denberg, T. D., Melhado, T. V., & Steiner, J. F. (2006). Patient treatment preferences in localized prostate carcinoma: the influence of emotion, misconception, and anecdote. Cancer, 107(3), 620-630.
  • Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., í– Bray, F. (2015). Cancer incidence and mortality worldwide: Sources, methods and major in GLOBOCAN 2012. International Journal of Cancer, 136, E359-E386. doi:10.1002/ijc.29210.
  • Gottlieb, B. H., & Wachala, E. D. (2007). Cancer support groups: a critical review of empirical studies. Psycho-Oncology, 16(5),
  • Professioni Infermieristiche
  • S. Sferrazza et al.
  • -400. doi: 10.1300/J077v23n01_02
  • Gray, R. E., Fitch, M. I., Phillips, C., Labrecque, M., & Klotz, L.
  • (1999). Presurgery experiences of prostate cancer patients and their spouses. Cancer Practice, 7(3), 130-135. doi: 10.1046/j.1523-5394.1999.07308.x
  • Henrikson, N. B., Ellis, W. J., & Berry, D. L. (2009). í¬It's not like I can change my mind laterí®: Reversibility and decision timing in prostate cancer treatment decision-making. Patient Education and Counseling, 77(2), 302-307. doi: 10.1016/j.pec.2009.03.017
  • Joanna Briggs Institute (JBI). (2014). Joanna Briggs Institute reviewers' manual: 2014 edition. Adelaide: Joanna Briggs Institute.
  • Kandasamy, S., Khalid, A. F., Majid, U., & Vanstone, M. (2017). Prostate cancer patient perspectives on the use of information in treatment decision-making: a systematic review and qualitative meta-synthesis. Ontario Health Technology Assessment Series, 17(7), 1-32.
  • Kazer, M. W., Harden, J., Burke, M., Sanda, M. G., Hardy, J., Bailey, D. E., & PROSTQA Study Group. (2011). The experiences of unpartnered men with prostate cancer: a qualitative analysis. Journal of Cancer Survivorship, 5(2), 132- 141. doi: 10.1007/s11764-010-0157-3
  • Le, Y. L., McFall, S. L., Byrd, T. L., Volk, R. J., Cantor, S. B., Kuban, D. A., & Mullen, P. D. (2016). Is "active surveillance" an acceptable alternative? A qualitative study of couples' decision-making about early-stage localized prostate cancer. Narrative Inquire Bioethics, 6(1), 51-61. doi: 10.1353/nib.2016.0006
  • Loblaw, A., Barkin, J., Buckley, R., Chung, H., Kell, J., Singal, R., ... Flax, S. (2017). Improving prostate cancer care collaboratively - a multidisciplinary, formal, consensus-based approach. Canadian Journal of Urology, 24(1), 8646-8650.
  • Maliski, S. L., Heilemann, M. V., & McCorkle, R. (2002). From "death sentence" to "good cancer": Couples' transformation of a prostate cancer diagnosis. Nursing Research, 51(6), 391-397.
  • Makoul, G., & Clayman, M. L. (2006). An integrative model of shared decision making in medical encounters. Patient Education and Counseling, 60(3):301–12.
  • Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group. (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Medicine, 6(6): e1000097.
  • Moses, K.A., Paciorek, A. T., Penson, D.F., Carroll, P.R., & Master, V.A. (2010). Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. Journal of Clinical Oncology, 28(6), 1069-1074. doi: 10.1200/JCO.2009.26.2469
  • Mottet, N., Bellmunt, J., Bolla, M., Briers, E., Cumberbatch, M.G., De Santis, M., ... Lam, T.B. (2017). EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and
  • local treatment with curative intent. European Urology, 71(4),
  • -629. doi: 10.1016/j.eururo.2016.08.003
  • O'Callaghan, C., Dryden, T., Hyatt, A., Brooker, J., Burney, S., Wootten, A. C., ... Schofield, P. (2014). What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option. Psycho-Oncology, 23,
  • -1398. doi: 10.1002/pon.3576
  • Oliver, A., & Evans, J. G. (2005). The paradox of promoting choice
  • in a collectivist system. Journal of Medical Ethics, 31(4), 187.
  • doi: 10.1136/jme.2005.011809.
  • Orom, H., Biddle, C., Underwood, W., Nelson, C. J., & Homish,
  • D. L. (2016). What Is a "Good" Treatment Decision? Decisional Control, Knowledge, Treatment Decision Making, and Quality of Life in Men with Clinically Localized Prostate Cancer. Medical decision-making: an International Journal of the Society for Medical Decision Making, 36(6), 714-25.
  • Schumm, K., Skea, Z., McKee, L., & N'Dow, J. (2010). "˜They're doing surgery on two people': a meta"ethnography of the influences on couples' treatment decision making for prostate cancer. Health Expectations, 13(4), 335-349. doi: 10.1111/j.1369-7625.2010.00624.x
  • O'Rourke, M. E., & Germino, B. B. (1998). Prostate cancer treatment decisions: a focus group exploration. Oncology Nursing Forum, 25(1), 97-104.
  • Shaw, E. K., Scott, J. G., & Ferrante, J. M. (2013). The influence of family ties on men's prostate cancer screening, biopsy, and treatment decisions. American Journal of Men's Health, 7(6), 461-471.
  • Thompson, I., Thrasher, J. B., Aus, G., Burnett, A. L., Canby- Hagino, E. D., Cookson, M. S., ... & Goldenberg, S. L. (2007). Guideline for the management of clinically localized prostate cancer: 2007 update. The Journal of Urology, 177(6), 2106-2131.
  • Volk, R. J., McFall, S. L., Cantor, S. B., Byrd, T. L., Le, Y. L., Kuban, D. A., & Mullen, P. D. (2014). "˜It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer. Psycho-Oncology, 23(4), 467-472. doi: 10.1002/pon.3444
  • Wallace, M., & Storms, S. (2007). The needs of men with prostate cancer: results of a focus group study. Applied Nursing Research, 20(4), 181-187. doi: 10.1016/j.apnr.2006.08.008.
  • Xu, J., Dailey, R. K., Eggly, S., Neale, A. V., & Schwartz, K. L. (2011). Men's perspectives on selecting their prostate cancer treatment. Journal of the National Medical Association, 103(6), 468-478.
  • Zeliadt, S. B., Ramsey, S. D., Penson, D. F., Hall, I. J., Ekwueme, D. U., Stroud, L., & Lee, J. W. (2006). Why do men choose one treatment over another? A review of patient decision making for localized prostate cancer. Cancer, 106, 1865-1874. doi: 10.1002/cncr.2182